Cuesta ÁM, et al. PLoS One. 2009, 4:e5381. doi: 10.1371/journal.pone.0005381

Sanchez-Martin D, et al.  J. Biol. Chem. 2011, 286:5197-5203. doi: 10.1074/jbc.M110.161927 

Cuesta ÁM, et al. MAbs 2012.. 4:226-32. doi: 10.4161/mabs.4.2.19140

Blanco-Toribio A, et al. MAbs 2013. 5:70-9. doi: 10.4161/mabs.22698

Alvarez-Cienfuegos A, et al. Sci. Rep. 2016. 6:28643. doi: 10.1038/srep28643.

Harwood SL, et al. Oncoimmunology 2018. doi: 10.1080/2162402X.2017.1377874.

Latest News

LeadArtis to present at the final Chemostart pitching initiative in recognition of its highly innovative R&D activity
The Chemostart initiative (sponsored by the Chemo company) launched in 2018 as a call for...
LeadArtis project finalist of the Kaertor and J&J innovation award in recognition of its highly innovative R&D activity
The Kærtor Foundation together with Janssen (a Johnson & Johnson company) launched in 2018...
Leadartis discloses the project: ATTACK-Cancer immunotherapy by bispecific antibodies that recruit T lymphocytes

LeadArtis is pleased to announce its participation as coordinator of the ATTACK project (Cancer...